Tevogen Bio Holdings Inc.（TVGN）内部人交易：高管与董事近期交易
过去 18 个月，共有 9 位内部人为 Tevogen Bio Holdings Inc.（TVGN）报告了 26 笔 Form 4 交易（最近一笔 2026-09-16）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-16 | Saadi Ryan H. | Chief Executive Officer | 买入 | 8.0M | $0 |
| 2026-09-16 | Desai Kirti | Chief Financial Officer | 买入 | 750,000 | $0 |
| 2026-09-15 | PODLOGAR SUSAN M | 董事 | 买入 | 75,000 | $0 |
| 2026-09-15 | Sordillo Victor J. | 董事 | 买入 | 75,000 | $0 |
| 2026-09-15 | Patton Curtis L. | 董事 | 买入 | 75,000 | $0 |
| 2026-09-15 | Goh Keow Lin | 董事 | 买入 | 75,000 | $0 |
| 2026-09-15 | Feike Jeffrey L. | 董事 | 买入 | 75,000 | $0 |
| 2026-07-10 | Desai Kirti | Chief Financial Officer | 买入 | 40,000 | $0 |
| 2026-07-10 | Saadi Ryan H. | Chief Executive Officer | 买入 | 1.2M | $0 |
| 2026-07-10 | Sordillo Victor J. | 董事 | 买入 | 40,000 | $0 |
| 2026-07-10 | Patton Curtis L. | 董事 | 买入 | 40,000 | $0 |
| 2026-07-10 | Goh Keow Lin | 董事 | 买入 | 40,000 | $0 |
| 2026-07-10 | PODLOGAR SUSAN M | 董事 | 买入 | 40,000 | $0 |
| 2026-07-10 | Feike Jeffrey L. | 董事 | 买入 | 40,000 | $0 |
| 2026-03-17 | Flomenberg Neal | Chief Scientific Officer, Global R&D Lead. All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026 | 卖出 | 19 | $147 |
| 2026-03-17 | Flomenberg Neal | Chief Scientific Officer, Global R&D Lead. All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026 | 卖出 | 452 | $3,282 |
| 2026-03-17 | Flomenberg Neal | Chief Scientific Officer, Global R&D Lead. All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026 | 卖出 | 501 | $3,206 |
| 2025-12-22 | Saadi Ryan H. | Chief Executive Officer | 卖出 | 50,000 | $0 |
| 2025-12-15 | Desai Kirti | Chief Financial Officer | 卖出 | 300,000 | $0 |
| 2025-12-12 | Saadi Ryan H. | Chief Executive Officer | 卖出 | 460,000 | $0 |
| 2025-08-18 | Saadi Ryan H. | Chief Executive Officer | 卖出 | 20,000 | $0 |
| 2025-07-01 | Khan Sadiq | Chief Commercial Officer | 买入 | 200,000 | $0 |
| 2025-07-01 | Saadi Ryan H. | Chief Executive Officer | 买入 | 8.0M | $0 |
| 2025-07-01 | Desai Kirti | Chief Financial Officer | 买入 | 750,000 | $0 |
| 2025-07-01 | Flomenberg Neal | Chief Scientific Officer, Global R&D Lead | 买入 | 300,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-16